← ANALYST RATINGS · TIPRANKS
Intuitive Surgical (ISRG): analyst forecast and price target
Analyst consensus
Strong Buy8 Buy1 Hold0 Sell
Ratings of 9 analysts in the last 3 months · top analysts only12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $471, the highest $500, the lowest $415. The average is +10.3% from the last price of $427.
Analyst ratings 29
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $473 → $479+1.3% | Buy | +12.3% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $471 → $477+1.3% | Buy | +11.8% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $483 → $490+1.4% | Buy | +14.8% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $458 → $464+1.3% | Hold | +8.7% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $481 → $488+1.5% | Buy | +14.4% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $464 → $471+1.5% | Buy | +10.4% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $400 → $415+3.8% | Hold | −2.7% | Assigned | 13.10.26on TipRanks 07:35 | −1.3%next day +0.6% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $500 | Buy | +17.2% | Reiterated | 13.10.26on TipRanks 06:26 | −1.3%next day +0.6% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $469 → $454−3.2% | Buy | +6.4% | Reiterated | 12.10.26on TipRanks 08:40 | +0.9%next day −1.3% | ↗ |
| Mike Kratky★★★★★★★★★★#1691 · hits 46% · avg +12.9% | Leerink Partners | $454 → $473+4.2% | Buy | +10.9% | Assigned | 12.10.26on TipRanks 07:35 | +0.9%next day −1.3% | ↗ |
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $470 | Buy | +10.1% | Reiterated | 07.10.26on TipRanks 07:26 | +2.7%next day +0.6% · 5 days +2.4% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $485 | Buy | +13.7% | Initiated | 07.10.26on TipRanks 03:55 | +2.7%next day +0.6% · 5 days +2.4% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $500 | Buy | +17.2% | Reiterated | 05.10.26on TipRanks 07:21 | +3.0%next day −1.0% · 5 days +4.8% | ↗ |
| Name not given | — | $575 | Buy | +34.8% | Reiterated | 01.10.26on TipRanks Oct 2 21:45 | −1.5%next day −3.1% · 5 days +2.2% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $470 | Buy | +10.1% | Reiterated | 21.09.26on TipRanks 06:10 | +0.6%next day +0.1% · 5 days +4.3% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | — | Buy | — | Reiterated | 28.08.26on TipRanks Aug 30 13:56 | +1.7%next day +1.4% · 5 days −1.7% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $500 | Buy | +17.2% | Upgrade | 12.08.26on TipRanks 06:30 | −0.2%next day −0.7% · 5 days −0.4% | ↗ |
| Lee Hambright★★★★★★★★★★#10167 · hits 49% · avg −1.6% | Bernstein | $685 | Buy | +60.5% | Reiterated | 11.08.26on TipRanks Aug 12 09:45 | +2.3%next day −0.2% · 5 days −2.1% | ↗ |
| Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% | TD Cowen | $485 | Buy | +13.7% | Reiterated | 03.08.26on TipRanks Aug 4 01:20 | +4.8%next day −3.7% · 5 days +2.8% | ↗ |
| Helen Fang★★★★★★★★★★#4974 · hits 50% · avg +6.9% | HSBC | $391 | Hold | −8.4% | Downgrade | 30.07.26on TipRanks 07:50 | −1.7%next day −0.6% · 5 days +2.3% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $487 | Buy | +14.1% | Reiterated | 23.07.26on TipRanks Jul 24 05:10 | −1.3%next day +1.5% · 5 days +5.8% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $450 | Buy | +5.5% | Reiterated | 21.07.26on TipRanks Jul 24 05:10 | −1.7%next day −2.6% · 5 days +4.3% | ↗ |
| Unknown Analyst | Mirae Asset | — | Buy | — | Upgrade | 21.07.26on TipRanks Jul 24 05:10 | −1.7%next day −2.6% · 5 days +4.3% | ↗ |
| Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% | Raymond James | $577 → $483−16.3% | Buy | +13.2% | Reiterated | 17.07.26on TipRanks 08:55 | −13.2%next day +2.4% · 5 days −1.7% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Buy | — | Reiterated | 17.07.26on TipRanks 07:06 | −13.2%next day +2.4% · 5 days −1.7% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $525 → $500−4.8% | Buy | +17.2% | Reiterated | 17.07.26on TipRanks 06:46 | −13.2%next day +2.4% · 5 days −1.7% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $510 | Buy | +19.5% | Reiterated | 17.07.26on TipRanks Jul 16 10:15 | +4.0%next day −13.2% · 5 days −15.8% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $670 → $550−17.9% | Buy | +28.9% | Assigned | 17.07.26on TipRanks Jul 14 09:35 | −7.1%next day +2.1% · 5 days −7.3% | ↗ |
| Shagun Singh Chadha★★★★★★★★★★#9557 · hits 48% · avg −0.4% | RBC Capital | $600 → $575−4.2% | Buy | +34.8% | Reiterated | 16.07.26on TipRanks Jul 17 07:06 | +4.0%next day −13.2% · 5 days −15.8% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $480 → $430−10.4% | Hold | +0.8% | Reiterated | 06.07.26on TipRanks 08:50 | +0.7%next day −0.8% · 5 days −5.7% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | $558 | Buy | +30.8% | Reiterated | 15.06.26on TipRanks 06:45 | −0.4%next day +0.7% · 5 days −0.6% | ↗ |
| Imron Zafar★★★★★★★★★★#3477 · hits 85% · avg +20.1% | Deutsche Bank | $440 → $366−16.8% | Sell | −14.2% | Reiterated | 02.06.26on TipRanks 09:35 | −2.6%next day +1.9% · 5 days +9.0% | ↗ |
| Unknown Analyst | Erste Group | — | Hold | — | Reiterated | 05.05.26on TipRanks May 12 21:02 | −1.0%next day −1.3% · 5 days −6.3% | |
| Unknown Analyst | Jefferies | $515 | Hold | +20.7% | Reiterated | 22.04.26on TipRanks 09:55 | +6.2%next day −0.6% · 5 days −6.2% | ↗ |
| Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% | DBS | $480 | Hold | +12.5% | Reiterated | 18.03.26on TipRanks Mar 19 07:55 | +0.4%next day +0.7% · 5 days −1.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Intuitive Surgical
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $490 at a price of $407 (+20.5%); now: $489 at $427 (+14.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Buy | 13 | 14 | 18 | 20 | 20 | 10 |
| Hold | 5 | 3 | 2 | 2 | 2 | 1 |
| Sell | 0 | 1 | 1 | 1 | 0 | 0 |
Earnings and sales forecast
Next report: 20.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.65 (from $2.53 to $2.76). Last quarter: $2.80.
Sales
Next quarter’s sales estimate — $2.9B (from $2.8B to $3.0B). Last quarter: $2.9B.
Best top-analyst consensus in the sector · Healthcare
About Intuitive Surgical
- CEO: David J. Rosa
- Employees: 17,021
- 1020 Kifer Road, Sunnyvale, CA, 94086-5304, US
- www.intuitive.com
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Data from the stock’s TipRanks forecast page, read 50 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗